Summary

Article Metadata

NAMSA Acquires WuXi AppTec Testing

This is a news story, published by financialpost, that relates primarily to NAMSA news.

emerging technologies news

For more emerging technologies news, you can click here:

more emerging technologies news

financialpost news

For more news from financialpost, you can click here:

more news from financialpost

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best tech news, business news, entertainment news, and much more. If you like emerging technologies news, you might also like this article about

global MedTech testing

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest MedTech innovation news, MedTech innovators news, emerging technologies news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

MedTech testing

financialpost

financialpost

•

NAMSA Acquires the U.S. Medical Device Testing Operations of WuXi AppTec, Solidifying its Position as the Leader in MedTech Testing and Clinical Research

financialpost

Summary

Nutrition label

77% Informative

NAMSA is a world-leading MedTech testing, clinical and regulatory consulting firm.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services to enable the pharmaceutical and life science industries to advance discoveries and deliver groundbreaking treatments to patients.

Both companies will work closely to ensure a smooth transition for employees and customers.

VR Score

79

Informative language

82

Neutral language

11

Article tone

formal

Language

English

Language complexity

87

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

15

https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.archimed.group&esheet=54181676&newsitemid=20250117736171&lan=en-US&anchor=archimed.group&index=7&md5=40f2fea6610d7b7d1c26454fa6d80707 https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnamsa.com%2Fservices%2Fconsulting%2F&esheet=54181676&newsitemid=20250117736171&lan=en-US&anchor=regulatory&index=3&md5=f9af0b2baac9a75d476c4d0ca23012bd https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.wuxiapptec.com%2F&esheet=54181676&newsitemid=20250117736171&lan=en-US&anchor=WuXi+AppTec&index=2&md5=0af090e52a77edf7526499e60510d54f https://www.reddit.com/submit?kind=link&url=https%3A//financialpost.com/news/namsa-acquires-the-u-s-medical-device-testing-operations-of-wuxi-apptec-solidifying-its-position-as-the-leader-in-medtech-testing-and-clinical-research&title=https://www.linkedin.com/sharing/share-offsite/?url=https://financialpost.com/news/namsa-acquires-the-u-s-medical-device-testing-operations-of-wuxi-apptec-solidifying-its-position-as-the-leader-in-medtech-testing-and-clinical-research https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.namsa.com%2F&esheet=54181676&newsitemid=20250117736171&lan=en-US&anchor=NAMSA&index=1&md5=5dd19dc2da14323e3b3101f1736a0185 https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnamsa.com%2Fservices%2Fclinical%2F&esheet=54181676&newsitemid=20250117736171&lan=en-US&anchor=clinical+evidence&index=4&md5=34db2195b1dee00082be4240d938aaf2 https://www.linkedin.com/sharing/share-offsite/?url= https%3A//financialpost.com/news/namsa-acquires-the-u-s-medical-device-testing-operations-of-wuxi-apptec-solidifying-its-position-as-the-leader-in-medtech-testing-and-clinical-research https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Farchimed.group%2F&esheet=54181676&newsitemid=20250117736171&lan=en-US&anchor=ARCHIMED&index=5&md5=651472f9bd4e59aaa6ec6cac13399f59 https://www.businesswire.com/news/home/20250117736171/en/https://www.reddit.com/submit?kind=link&url=https%3A//financialpost.com/news/namsa-acquires-the-u-s-medical-device-testing-operations-of-wuxi-apptec-solidifying-its-position-as-the-leader-in-medtech-testing-and-clinical-research&title=NAMSA%20Acquires%20the%20U.S.%20Medical%20Device%20Testing%20Operations%20of%20WuXi%20AppTec%2C%20Solidifying%20its%20Position%20as%20the%20Leader%20in%20MedTech%20Testing%20and%20Clinical%20Research https://twitter.com/intent/tweet?url=https%3A//financialpost.com/news/namsa-acquires-the-u-s-medical-device-testing-operations-of-wuxi-apptec-solidifying-its-position-as-the-leader-in-medtech-testing-and-clinical-research&text=NAMSA%20Acquires%20the%20U.S.%20Medical%20Device%20Testing%20Operations%20of%20WuXi%20AppTec%2C%20Solidifying%20its%20Position%20as%20the%20Leader%20in%20MedTech%20Testing%20and%20Clinical%20Research&via=https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnamsa.com%2F&esheet=54181676&newsitemid=20250117736171&lan=en-US&anchor=namsa.com&index=6&md5=9aa0da632403d7712fbb3672808f0f69 https://twitter.com/intent/tweet?url= https%3A//financialpost.com/news/namsa-acquires-the-u-s-medical-device-testing-operations-of-wuxi-apptec-solidifying-its-position-as-the-leader-in-medtech-testing-and-clinical-research&text=NAMSA%20Acquires%20the%20U.S.%20Medical%20Device%20Testing%20Operations%20of%20WuXi%20AppTec%2C%20Solidifying%20its%20Position%20as%20the%20Leader%20in%20MedTech%20Testing%20and%20Clinical%20Research&via=https://www.tumblr.com/widgets/share/tool?canonicalUrl=https://financialpost.com/news/namsa-acquires-the-u-s-medical-device-testing-operations-of-wuxi-apptec-solidifying-its-position-as-the-leader-in-medtech-testing-and-clinical-research&title=NAMSA%20Acquires%20the%20U.S.%20Medical%20Device%20Testing%20Operations%20of%20WuXi%20AppTec%2C%20Solidifying%20its%20Position%20as%20the%20Leader%20in%20MedTech%20Testing%20and%20Clinical%20Research

Source diversity

6

cts.businesswire.com www.reddit.com www.linkedin.com www.businesswire.com twitter.com www.tumblr.com

Affiliate links

1

https://www.tkqlhce.com/click-8833686-11570746?url=https://financialpost.newspapers.com/?xid=3369/

Read full article